← Leaderboards
Michael J Toth
University Of Vermont &St Agric College
$13,490,593
Attributed
$16,041,109
Total exposure
22
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$16,041,109 · 22
By mechanism
R01$12,980,879 · 7
M01$1,477,749 · 11
R21$1,138,737 · 3
K01$443,744 · 1
Top collaborators
- Daniel Clark Files5 shared
- Renee D Stapleton5 shared
- Matthew E Poynter3 shared
- Bruce Beynnon2 shared
- Benjamin T Suratt2 shared
Most similar at University Of Vermont &St Agric College
Same institution · by research overlap
- Rup Tandan$468,554
- Dwight E. Matthews$4,596,582
- Bruce Beynnon$9,224,231
- Teresa Ruiz$5,085,267
- Naomi K Fukagawa$3,762,860
Others in their field
Top investigators on “Muscle Fibers”
- Steven J Burden · New York University School Of Medicine$16,000,720
- Terry L. Powley · Purdue University West Lafayette$15,294,923
- Osvaldo Delbono · Wake Forest University Health Sciences$14,755,642
- Jianjie Ma · Case Western Reserve University$14,695,150
- Helen M Blau · Stanford University$14,377,662
- Stephen B Kritchevsky · Mayo Clinic Rochester$13,660,193
Research focus
Muscle FibersMuscleResponseFunctional DisorderExerciseMeasurementMuscle FunctionDisabilityMolecularSkeletal MuscleTissuesProteinsSeminalSkeletal Muscle WastingBaseMechanicsInstitutionAtrophicClinical CarePublic Health RelevanceFiberProductionTrainingMicrofilaments
Grant awards (56)
Development of a clinically relevant mouse model of lung cancer cachexia to study pathoetiology and therapeutic strategies$173,208
R21 · FY2024 · CA · contact PI
Development of a clinically relevant mouse model of lung cancer cachexia to study pathoetiology and therapeutic strategies$218,790
R21 · FY2023 · CA · contact PI
Effects of Exercise on Inflammation-Induced Lung and Muscle Injury in Critical Illness (NEXIS-FLAME)$747,278
R01 · FY2021 · HL
Skeletal Muscle Atrophy and Dysfunction in Human Cancer$462,369
R01 · FY2021 · AR · contact PI
Effects of Exercise on Inflammation-Induced Lung and Muscle Injury in Critical Illness (NEXIS-FLAME)$63,581
R01 · FY2021 · HL
Effects of Exercise on Inflammation-Induced Lung and Muscle Injury in Critical Illness (NEXIS-FLAME)$757,241
R01 · FY2020 · HL
Skeletal Muscle Atrophy and Dysfunction in Human Cancer$476,671
R01 · FY2020 · AR · contact PI
Skeletal Muscle Atrophy and Dysfunction Following Total Knee Arthroplasty$434,891
R01 · FY2020 · AG · contact PI
Effects of Exercise on Inflammation-Induced Lung and Muscle Injury in Critical Illness (NEXIS-FLAME)$778,606
R01 · FY2019 · HL
Skeletal Muscle Atrophy and Dysfunction Following Total Knee Arthroplasty$437,783
R01 · FY2019 · AG · contact PI
Skeletal Muscle Atrophy and Dysfunction in Human Cancer$327,386
R01 · FY2019 · AR · contact PI
Effects of Exercise on Inflammation-Induced Lung and Muscle Injury in Critical Illness (NEXIS-FLAME)$803,292
R01 · FY2018 · HL
Skeletal Muscle Atrophy and Dysfunction Following Total Knee Arthroplasty$422,667
R01 · FY2018 · AG · contact PI
Skeletal Muscle Atrophy and Dysfunction Following Total Knee Arthroplasty$424,175
R01 · FY2017 · AG · contact PI
Skeletal Muscle Atrophy and Dysfunction in Human Cancer$419,836
R01 · FY2017 · AR · contact PI
Prevention of Skeletal Muscle Adaptations to Traumatic Knee Injury and Surgery$171,600
R21 · FY2017 · AR · contact PI
Alternative exercise modalities to improve skeletal muscle function in cancer survivors$169,244
R21 · FY2017 · CA · contact PI
Skeletal Muscle Atrophy and Dysfunction Following Total Knee Arthroplasty$454,703
R01 · FY2016 · AG · contact PI
Skeletal Muscle Atrophy and Dysfunction in Human Cancer$418,961
R01 · FY2016 · AR · contact PI
Prevention of Skeletal Muscle Adaptations to Traumatic Knee Injury and Surgery$204,435
R21 · FY2016 · AR · contact PI
Alternative exercise modalities to improve skeletal muscle function in cancer survivors$201,460
R21 · FY2016 · CA · contact PI
Muscle disuse and contractile dysfunction in the elderly$378,836
R01 · FY2014 · AG · contact PI
Muscle disuse and contractile dysfunction in the elderly$358,152
R01 · FY2013 · AG · contact PI
Muscle disuse and contractile dysfunction in the elderly$379,161
R01 · FY2012 · AG · contact PI
Muscle disuse and contractile dysfunction in the elderly$379,330
R01 · FY2011 · AG · contact PI
Muscle disuse and contractile dysfunction in the elderly$397,633
R01 · FY2010 · AG · contact PI
SKELETAL MUSCLE CONTRACTILE DYSFUNCTION IN HEART FAILURE$205,395
M01 · FY2010 · RR · contact PI
EFFECT OF OVARIAN SUPPRESSION ON PROTEIN METABOLISM$3,422
M01 · FY2010 · RR · contact PI
Skeletal muscle contractile dysfunction in heart failure$371,958
R01 · FY2009 · HL · contact PI
SKELETAL MUSCLE CONTRACTILE DYSFUNCTION IN HEART FAILURE$328,255
M01 · FY2009 · RR · contact PI
EFFECT OF OVARIAN SUPPRESSION ON PROTEIN METABOLISM$50,358
M01 · FY2009 · RR · contact PI
MUSCLE DISUSE AND CONTRACTILE DYSFUNCTION IN THE ELDERLY$4,664
M01 · FY2009 · RR · contact PI
SKELETAL MUSCLE CONTRACTILE DYSFUNCTION IN HEART FAILURE$438,363
M01 · FY2008 · RR · contact PI
Skeletal muscle contractile dysfunction in heart failure$371,958
R01 · FY2008 · HL · contact PI
EFFECT OF OVARIAN SUPPRESSION ON PROTEIN METABOLISM$33,721
M01 · FY2008 · RR · contact PI
Skeletal muscle contractile dysfunction in heart failure$371,958
R01 · FY2007 · HL · contact PI
Effects of ovarian suppression on substrate metabolism$359,123
R01 · FY2007 · AG · contact PI
SKELETAL MUSCLE CONTRACTILE DYSFUNCTION IN HEART FAILURE$78,606
M01 · FY2007 · RR · contact PI
EFFECT OF OVARIAN SUPPRESSION ON PROTEIN METABOLISM$45,790
M01 · FY2007 · RR · contact PI
Skeletal muscle contractile dysfunction in heart failure$392,427
R01 · FY2006 · HL · contact PI
Effects of ovarian suppression on substrate metabolism$369,849
R01 · FY2006 · AG · contact PI
EFFECT OF OVARIAN SUPPRESSION ON PROTEIN METABOLISM$93,094
M01 · FY2006 · RR · contact PI
SKELETAL MUSCLE PROTEIN METABOLISM IN HEART FAILURE$1,596
M01 · FY2006 · RR · contact PI
Effects of ovarian suppression on substrate metabolism$378,750
R01 · FY2005 · AG
EFFECT OF OVARIAN SUPPRESSION ON PROTEIN METABOLISM$77,160
M01 · FY2005 · RR
SKELETAL MUSCLE PROTEIN METABOLISM IN HEART FAILURE$923
M01 · FY2005 · RR
Effects of ovarian suppression on substrate metabolism$378,750
R01 · FY2004 · AG
Effect of Ovarian Suppression on Protein Metabolism$113,456
M01 · FY2004 · RR
Skeletal Muscle Protein Metabolism in Heart Failure$2,946
M01 · FY2004 · RR
Effects of ovarian suppression on substrate metabolism$378,750
R01 · FY2003 · AG
SKELETAL MUSCLE PROTEIN METABOLISM IN HEART FAILURE$114,895
K01 · FY2003 · AR
SKELETAL MUSCLE PROTEIN METABOLISM IN HEART FAILURE$111,792
K01 · FY2002 · AR
SKELETAL MUSCLE PROTEIN METABOLISM IN HEART FAILURE$143,520
R01 · FY2001 · AG
SKELETAL MUSCLE PROTEIN METABOLISM IN HEART FAILURE$108,780
K01 · FY2001 · AR
SKELETAL MUSCLE PROTEIN METABOLISM IN HEART FAILURE$141,284
R01 · FY2000 · AG
SKELETAL MUSCLE PROTEIN METABOLISM IN HEART FAILURE$108,277
K01 · FY2000 · AR